Consolidated Statements Of Cash Flows (USD $) In Thousands	6 Months Ended
	Sep. 10, 2011	Sep. 11, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (255,884)	$ (274,820)
Adjustments to reconcile net loss to net cash used in operating activities (see next page)	151,393	195,938
Other changes in assets and liabilities:
Decrease in receivables	54,646	17,534
Decrease (increase) in inventories	37,590	(7,209)
Increase in prepaid expenses and other current assets	(11,960)	(7,560)
Increase in other assets	(14,549)	(2,799)
(Decrease) increase in accounts payable	(9,662)	13,319
(Decrease) increase in accrued salaries, wages and benefits, and taxes	(2,238)	2,308
Increase in other accruals	80,169	5,917
Decrease in other non-current liabilities	(74,003)	(36,952)
Other operating activities, net	129	(99)
Payments for reorganization items	(23,984)
Net cash used in operating activities	(68,353)	(94,423)
CASH FLOWS FROM INVESTING ACTIVITIES:
Expenditures for property	(17,282)	(43,447)
Proceeds from disposal of property	8,789	8,739
Proceeds from flood insurance		4,910
Proceeds from sale of assets held for sale	38,302
(Increase) decrease in restricted cash	(2,449)	302
Proceeds from sale of pharmacy assets	4,785
Net cash provided by (used in) investing activities	32,145	(29,496)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt		800
Principal payments on long-term debt	(99)	(134)
Proceeds under revolving lines of credit		201,600
Principal payments on revolving lines of credit		(200,700)
Principal payments on long-term real estate liabilities	(616)	(631)
Principal payments on capital leases	(5,610)	(6,317)
Decrease in book overdrafts	(6,881)	(21,804)
Payments of financing fees for debtor-in-possession financing	(1,624)
Deferred financing fees		(6)
Dividends paid on preferred stock		(7,000)
Proceeds from exercises of stock options		28
Net cash used in financing activities	(14,830)	(34,164)
Net decrease in cash and cash equivalents	(51,038)	(158,083)
Cash and cash equivalents at beginning of year	352,607	252,426
Cash and cash equivalents at end of period	301,569	94,343
ADJUSTMENTS TO RECONCILE NET LOSS TO NET CASH USED IN OPERATING ACTIVITIES:
Depreciation and amortization	101,588	121,897
Goodwill, trademark and long-lived asset impairment	79,542	35,648
Impairment of long-lived assets in the normal course of business	1,465	1,144
Self-insurance reserve	3,127	21,661
Nonoperating income	(91)	(10,454)
Non-cash interest expense	10,104	23,258
Stock compensation expense (income)	1,509	(101)
Pension withdrawal costs	13,923
Employee benefit related costs	2,111	6,713
Asset disposition initiatives relating to discontinued operations		4
Non-cash occupancy charges for locations closed in the normal course of business	1,580	466
Adjustment to occupancy reserves	92,773
Losses relating to Hurricane Irene	1,000
Gain on disposal of owned property and write-down of property, net	(499)	(1,807)
Gain on disposal of discontinued operations		(79)
Gain on sale of pharmacy assets	(4,785)
Gain on sale of assets held for sale	(29,120)
Amortization of deferred real estate income	(1,777)	(2,412)
C&S contract effect	9,184
Provision for deferred income taxes	(1,719)
Reorganization items, net relating to continuing operations	(95,026)
Reorganization items, net relating to discontinued operations	(34,209)
Financing fees	713
Total adjustments to net loss	$ 151,393	$ 195,938